InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Discover the complete record of transactions filed by Silberman David, Chief Financial Officer. Officer active across 2 companies, notably Oramed Pharmaceuticals INC.. In total, 7 filings have been published. History available since 1 September 2021. The latest transaction was disclosed on 29 July 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Silberman David
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
19,500 shares0Ordinary SharesSEC:0001178913-26-003727:0
136,500 sharesCommon StockSEC:0001209191-24-001146:0
24,500 sharesCommon StockSEC:0001209191-23-033141:0
97,500 sharesCommon StockSEC:0001209191-23-024936:0
39,000 sharesCommon StockSEC:0001209191-22-043765:0
19,000 sharesCommon StockSEC:0001213900-22-000805:0
50,000 shares0Common StockSEC:0001213900-21-046413:0
7 of 7 declarations
About Silberman David
Silberman David is Chief Financial Officer at Oramed Pharmaceuticals INC. and COMPUGEN LTD. He has 7 filings in total, and across the 7 sampled filings the transactions are of Attribution nature, with a period ranging from 2021-09-02 to 2026-07-30 and buy and sell amounts of EUR 0.
